BioSpace News Archive

LabCorp® announced that its Zero Coupon Convertible Subordinated Notes due 2021 may be converted as set forth below.

Aaron Sato, Ph.D., Chief Scientific Officer of Twist Biopharma, to Deliver Keynote Address

Randomized, 12-Month, Pivotal Trial Evaluating the Safety and Efficacy of Patidegib Topical Gel to Reduce the Disease Burden of Chronic BCCs in Patients with Rare Form of Skin Cancer

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the Marketing Authorisation Application (MAA) for its investigational agent, HTX-011,

Astellas Pharma Inc. (TSE: 4503) (President and CEO: Kenji Yasukawa, Ph.D. “Astellas”) today announced results from the Phase 3 ADMIRAL clinical trial comparing XOSPATA® (gilteritinib) to salvage chemotherapy in adult patients with relapsed or refractory (resistant to treatment) Acute Myeloid Leukemia (AML) with a FLT3 mutation

drTung’s was a winner of this year’s iF DESIGN AWARD, a world-renowned design prize. The winning product, drTung’s Activated Charcoal Floss, won in the discipline PACKAGING.

Debiopharm announces the poster presentations of preclinical data for Debio 0123 and clinical data for Debio 1143 and Debio 1347

Dyadic International, Inc. (the “Company”) (OTCQX: DYAI), , today announced that its President and Chief Executive Officer, Mark Emalfarb will present live at VirtualInvestorConferences.com on April 4th.

“I’m not sure I’m even going to call them ‘ambulances’,” says MRC Director, Dr. Demetri Yannopoulos. “They’re more like an emergency department substation that’s mobile. I believe the MOBYBOX system’s small size and mobility make it the ideal ECMO device for super ambulances.”

Interested parties can access the conference call by dialing 844-634-1444 within the U.S. and Canada, or 1-615-247-0253 internationally, using the passcode 7459328.